1-1 of 1
Daniel Nathan Egan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Clinical Trials & Observations
Matthew S. Davids, Danielle M Brander, Yesid Alvarado Valero, Catherine Sibyl Diefenbach, Daniel Nathan Egan, Shira Naomi Dinner, Nathalie Javidi-Sharifi, Monzr M. Al Malki, Kebede Begna, Vijaya R. Bhatt, Sameem Abedin, Rachel Cook, Mary C. Collins, Carly Roleder, Edward C Dominguez, Prabhu Rajagopalan, Sandra E Wiley, Richard G Ghalie, Alexey V Danilov
Journal: Blood Advances
Blood Adv bloodadvances.2024014633.
https://doi.org/10.1182/bloodadvances.2024014633
Published: 2024
Includes: Supplemental data